Literature DB >> 23595587

Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review.

S Scerra1, H Coignard-Biehler, F Lanternier, F Suarez, C Charlier-Woerther, M-E Bougnoux, J Gilquin, M Lecuit, O Hermine, O Lortholary.   

Abstract

Toxoplasmosis can be a severe opportunistic infection in patients with acquired immunodeficiency syndrome (AIDS), and also among solid organ transplant and allogeneic hematopoietic stem cell transplant (HSCT) patients. Patients with low-grade or chronic hematologic malignancies are treated with increasing immunosuppressive regimens and, therefore, represent an emerging population at risk for opportunistic diseases. We report here two cases of disseminated toxoplasmosis occurring in non-allografted hematologic patients with chronic lymphoproliferations. A review of 44 cases from the literature reveals that toxoplasmosis occurs increasingly in indolent B cell lymphoproliferative disorders. Aggressive lymphoproliferations, adenosine analogs, autologous HSCT, and the absence of chemoprophylaxis are the main risk factors for opportunistic toxoplasmosis. The central nervous system is the main organ involved. Fever is only present in half of all cases. Latent Toxoplasma cysts reactivation (LTCR) is the most common, but primary infection occurs in about 20% of cases. Global mortality is over 50%.

Entities:  

Mesh:

Year:  2013        PMID: 23595587     DOI: 10.1007/s10096-013-1879-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  65 in total

1.  Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  R Martino; S Bretagne; M Rovira; A J Ullmann; J Maertens; T Held; E Deconinck; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

Review 2.  Strategies in the management of alemtuzumab-related side effects.

Authors:  Anders Osterborg; Claes Karlsson; Jeanette Lundin; Eva Kimby; Håkan Mellstedt
Journal:  Semin Oncol       Date:  2006-04       Impact factor: 4.929

3.  Disseminated toxoplasmosis following autologous bone marrow transplantation.

Authors:  F Geissmann; F Derouin; J P Marolleau; C Gisselbrecht; P Brice
Journal:  Clin Infect Dis       Date:  1994-10       Impact factor: 9.079

4.  Small nodular pattern in the lungs due to opportunistic toxoplasmosis.

Authors:  O Prosmanne; J Chalaoui; J Sylvestre; R Lefebvre
Journal:  J Can Assoc Radiol       Date:  1984-06

Review 5.  Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).

Authors:  M Dedicoat; N Livesley
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

6.  Opportunistic toxoplasmic retinochoroiditis following chemotherapy for systemic lymphoma. A light and electron microscopic study.

Authors:  J H Yeo; F A Jakobiec; T Iwamoto; G Richard; I Kreissig
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

7.  [Fatal cerebral toxoplasmosis in a leukemia child in remission].

Authors:  Y Bertrand; N Fegueux; M Rodière; R Jean
Journal:  Arch Fr Pediatr       Date:  1988-05

8.  Toxoplasma gondii infection in patients with hematological malignancies.

Authors:  Livio Pagano; Giulio Trapè; Rossana Putzulu; Cecilia Caramatti; Marco Picardi; Annamaria Nosari; Saverio Cinieri; Morena Caira; Albano Del Favero
Journal:  Ann Hematol       Date:  2004-07-03       Impact factor: 3.673

Review 9.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

10.  Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation.

Authors:  Orli Megged; Itamar Shalit; Isaac Yaniv; Jerry Stein; Salvador Fisher; Itzhak Levy
Journal:  Pediatr Transplant       Date:  2008-01-08
View more
  9 in total

Review 1.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

2.  Toxoplasmosis complicating lung cancer: a case report.

Authors:  Nianhong Lu; Caihong Liu; Jiangyuan Wang; Ying Ding; Qing Ai
Journal:  Int Med Case Rep J       Date:  2015-01-22

3.  Seroprevalence and Molecular Evaluation of Toxoplasmosis in Patients Undergoing Chemotherapy for Malignancies in the Bushehr Province, Southwest Iran.

Authors:  Afshin Barazesh; Bahador Sarkari; Farhad Mehrabi Sisakht; Samaneh Abdolahi Khabisi; Reza Nikbakht; Mohammad Reza Ravanbod
Journal:  Jundishapur J Microbiol       Date:  2016-08-17       Impact factor: 0.747

4.  Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant.

Authors:  Taichi Ikebe; Hitohiro Sasaki; Hiroyuki Takata; Yasuhiko Miyazaki; Eiichi Ohtsuka; Yoshio Saburi; Masao Ogata; Kuniaki Shirao
Journal:  Intern Med       Date:  2016-11-01       Impact factor: 1.271

5.  High frequency of infection of lung cancer patients with the parasite Toxoplasma gondii.

Authors:  Jaroslav Bajnok; Muyassar Tarabulsi; Helen Carlin; Kevin Bown; Thomas Southworth; Josiah Dungwa; Dave Singh; Zhao-Rong Lun; Lucy Smyth; Geoff Hide
Journal:  ERJ Open Res       Date:  2019-05-28

6.  Toxoplasma gondii infection in children with lymphoma in Eastern China: seroprevalence, risk factors and case-control studies.

Authors:  Yuhe Duan; Yunlai Zhi; Yusheng Liu; Na Zhou; Fujiang Li; Xiwei Hao; Xiangyan Zhang; Qian Dong; Lili Chen
Journal:  Epidemiol Infect       Date:  2019-11-26       Impact factor: 2.451

7.  Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center.

Authors:  Sejal Morjaria; David J Epstein; Fabian A Romero; Ying Taur; Susan K Seo; Genovefa A Papanicolaou; Vaios Hatzoglou; Marc Rosenblum; Miguel-Angel Perales; Michael Scordo; Anna Kaltsas
Journal:  Open Forum Infect Dis       Date:  2016-03-30       Impact factor: 3.835

8.  Toxoplasmosis in a patient receiving ixekizumab for psoriasis.

Authors:  Yolanka Lobo; Teagan Holland; Lynda Spelman
Journal:  JAAD Case Rep       Date:  2020-02-19

9.  Increased Risk of Toxoplasma gondii Infection in Patients with Colorectal Cancer in Eastern China: Seroprevalence, Risk Factors, and a Case-Control Study.

Authors:  Yang Yu; Dong Guo; Tingting Qu; Shuchao Zhao; Chang Xu; Longlong Wang; Zhongjun Wang; Haiyang Fu; Xiangyan Zhang; Na Zhou
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.